Samsung Hit by $191 Million OLED Patent Verdict
By Reuters | 04 Nov, 2025
The electronics giant was found to have infringed two Pictiva patents relating to technology for enhancing OLED performance.
Samsung Electronics owes patent owner Pictiva Displays $191.4 million in damages for infringing two U.S. patents covering organic light-emitting diode technology, a jury in Texas federal court said on Monday.
Pictiva convinced the jury that a wide range of Samsung devices violate Pictiva's patent rights in technology for enhancing the resolution, brightness and power efficiency of OLED displays.
Pictiva Managing Director Angela Quinlan said in a statement the verdict "validates the strength of the Pictiva intellectual property."
Samsung Electronics said it would appeal.
"We intend to appeal the verdict related to the two patents. We have already filed a petition to invalidate the relevant patents, which is currently under review by the United States Patent and Trademark Office," the company said in a statement.
The verdict is one of several recent large awards won by patent owners suing Samsung in the same Marshall, Texas, court over technology in its devices.
Ireland-based Pictiva, a subsidiary of patent licensing company Key Patent Innovations, owns hundreds of patents covering OLED technology invented by photonics company OSRAM in the early 2000s.
Pictiva alleged in its 2023 lawsuit that Samsung's Galaxy smartphones, televisions, computers, wearables and other products incorporate Pictiva's technology for improving OLED displays. Samsung denied the allegations and argued the patents were invalid.
(Reporting by Blake Brittain in Washington; Additional reporting by Heekyong Yang in Seoul; Editing by Richard Chang, Ed Davies)
Recent Articles
- Vietnamese Fishermen Faced Down KKK Violence
- 2026 Looks Big for Quantum Computing Real-World Deployment
- Xi Uses Call with Saudi Crown Prince to Step into Strait of Hormuz Conflict
- How Don Can Leave a Very Cool and Smart Legacy After All
- Samsung SDI Inks EV Battery Deal with Mercedes-Benz
- Psychedelic Drug Developer Shares Soar on Expedited FDA Approval
- Tesla's Energy Storage Division to Offset Weak EV Margins
- Jamie Dimon, Big Banks Grumble at Uneven Impact of New Bank Capital Rules
- Hormuz Shipping Reverts to Near Standstill
- Homebuilders Face Another Gloomy Year As War Adds to Hardships
